연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1971. Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Sim SH, Kim S, Kim TM, Jeon YK, Nam SJ, Ahn YO, Keam B, Park HH, Kim DW, Kim CW, Heo DS.
Am J Pathol. 2017 May;187(5):980-986. doi: 10.1016/j.ajpath.2017.01.004. Epub 2017 Mar 9.
Link
1970. Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors.
Kim TM, Lee KW, Oh DY, Lee JS, Im SA, Kim DW, Han SW, Kim YJ, Kim TY, Kim JH, Han H, Kim WH, Bang YJ.
Cancer Res Treat. 2017 Aug 29. doi: 10.4143/crt.2017.303. [Epub ahead of print]
Link
1969. Comparison of Native Escherichia Coli L-Asparaginase Versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone (IMEP), in Extranodal NK/T Cell Lymphoma, Nasal Type (NTCL).
Kim HJ, Ock CY, Kim TM, Lee SH, Lee JY, Jung SH, Cho YS, Kim M, Keam B, Kim DW, Kim IH, Heo DS.
Cancer Res Treat. 2017 Jul 3. doi: 10.4143/crt.2017.051. [Epub ahead of print]
Link
1968. Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer.
Son HY, Hwangbo Y, Yoo SK, Im SW, Yang SD, Kwak SJ, Park MS, Kwak SH, Cho SW, Ryu JS, Kim J, Jung YS, Kim TH, Kim SJ, Lee KE, Park DJ, Cho NH, Sung J, Seo JS, Lee EK, Park YJ, Kim JI
Nat Commun. 2017 Jul 13;8:15966. doi: 10.1038/ncomms15966.
Link
1967. A copy number variation in PKD1L2 is associated with colorectal cancer predisposition in korean population.
Park C, Kim JI, Hong SN, Jung HM, Kim TJ, Lee S, Kim SJ, Kim HC, Kim DH, Cho B, Park JH, Sung J, Lee DS, Kang M, Son HJ, Kim YH
Int J Cancer. 2017 Jan 1;140(1):86-94. doi: 10.1002/ijc.30421. Epub 2016 Oct 3.
Link
1966. Findings of a 1303 Korean whole-exome sequencing study.
Kwak SH, Chae J, Choi S, Kim MJ, Choi M, Chae JH, Cho EH, Hwang TJ, Jang SS, Kim JI, Park KS, Bang YJ
Exp Mol Med. 2017 Jul 14;49(7):e356. doi: 10.1038/emm.2017.142.
Link
1965. Impact of interim progression during the surgery-to-radiotherapy interval and its predictors in glioblastoma treated with temozolomide-based radiochemotherapy.
Wee CW, Kim E, Kim TM, Park CK, Kim JW, Choi SH, Yoo RE, Lee ST, Kim IH.
J Neurooncol. 2017 Aug;134(1):169-175. doi: 10.1007/s11060-017-2505-x. Epub 2017 May 25.
Link
1964. Does fluid collection impact radiotherapy outcomes after wide excision of lower extremity soft tissue sarcoma?
Choi N, Kim JY, Yu T, Kang HC, Kim HS, Kim HJ, Kim IH.
Jpn J Clin Oncol. 2017 Nov 9:1-7. doi: 10.1093/jjco/hyx162. [Epub ahead of print]
Link
1963. Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies
Jeonghwan Youk, Young-Sook Kim, Jung-Ah Lim, Dong-Yeop Shin, Youngil Koh, Soon-Tae Lee, Inho Kim
PLoS One. 2017 Aug 21;12(8):e0183491. doi:10.1371/journal.pone.0183491. eCollection 2017
Link
1962. KML001 and doxercalciferol induce synergistic antileukemic effect in acute lymphoid leukemia cells
YANG LIU, DONG-YEOP SHIN, SOMI OH, SUJONG KIM, YOUNGIL KOH and INHO KIM
Oncol Rep. 2017 Jul;38(1):481-487. doi: 10.3892/or.2017.5688. Epub 2017 Jun 1
Link